Direct Rx recalls
4 notices naming Direct Rx as the recalling firm, since April 23, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Direct Rx: DULOXETINE D/R
Hazard (FDA): CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
FDAMedicines
Direct Rx: Duloxetine D/R and 1 more
Hazard (FDA): CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
FDAMedicines
Direct Rx: CIPROFLOXACIN OPHTH SOLUTION
Hazard (FDA): Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
FDAMedicines